Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer modelsFolashade Otegbeye, David N. Wald|PLoS ONE|2018Cited by 143
Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin LymphomaZachary Jackson, David N. Wald|Cancer Discovery|2022Cited by 87